FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Harriet Smith

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Geographic Areas

New Mexico

Co-author Network

Publications

TOP 3
Harriet O Smith; Nicole D Stephens; Tao Wang; Clifford R Qualls; Elizabeth Burton; Tal Fligelman; Jeffrey K Griffith; Chang-Yun Lin; Jeffrey W Pollard
The clinical significance of inflammatory cytokines in primary cell culture in endometrial carcinoma.
June Hou; Rebecca Levine; Thomas C McAndrew; Abdissa Negassa; Harriet O Smith; David Smotkin; Mark Suhrland; Robert Grossberg; Mark H Einstein
High prevalence of high grade anal intraepithelial neoplasia in HIV-infected women screened for anal cancer.
June Hou; Gary L Goldberg; Clifford R Qualls; Dennis Kuo; Aliza Forman; Harriet O Smith
Risk factors for poor prognosis in microinvasive adenocarcinoma of the uterine cervix (IA1 and IA2): a pooled analysis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Harriet Smith (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Harriet O Smith; Nicole D Stephens; Tao Wang; Clifford R Qualls; Elizabeth Burton; Tal Fligelman; Jeffrey K Griffith; Chang-Yun Lin; Jeffrey W Pollard
The clinical significance of inflammatory cytokines in primary cell culture in endometrial carcinoma.
Molecular oncology 2013;7(1):41-54.
2012: June Hou; Rebecca Levine; Thomas C McAndrew; Abdissa Negassa; Harriet O Smith; David Smotkin; Mark Suhrland; Robert Grossberg; Mark H Einstein
High prevalence of high grade anal intraepithelial neoplasia in HIV-infected women screened for anal cancer.
Journal of acquired immune deficiency syndromes (1999) 2012;60(2):169-72.
2011: June Hou; Gary L Goldberg; Clifford R Qualls; Dennis Kuo; Aliza Forman; Harriet O Smith
Risk factors for poor prognosis in microinvasive adenocarcinoma of the uterine cervix (IA1 and IA2): a pooled analysis.
Gynecologic oncology 2011;121(1):135-42.
2010: Gloria Huang; Marc Gunter; Rebecca C Arend; Maomi Li; Hugo Arias-Pulido; Eric R Prossnitz; Gary L Goldberg; Harriet O Smith
Co-expression of GPR30 and ERbeta and their association with disease progression in uterine carcinosarcoma.
American journal of obstetrics and gynecology 2010;203(3):242.e1-5.
2010: Houman M Fekrazad; Claire F Verschraegen; Melanie Royce; Harriet O Smith; Fa Chyi Lee; Ian Rabinowitz
A phase I study of flavopiridol in combination with gemcitabine and irinotecan in patients with metastatic cancer.
American journal of clinical oncology 2010;33(4):393-7.
2010: Gloria Huang; Jurriaan Brouwer-Visser; Marissa J Ramirez; Christine H Kim; Tiffany Hebert; Juan Lin; Hugo Arias-Pulido; Clifford R Qualls; Eric R Prossnitz; Gary L Goldberg; Harriet O Smith; Susan B. Horwitz
Insulin-like growth factor 2 expression modulates Taxol resistance and is a candidate biomarker for reduced disease-free survival in ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(11):2999-3010.
2009: Hugo Arias-Pulido; Harriet O Smith; Nancy E Joste; Therese Bocklage; Clifford R Qualls; Allison Chavez; Eric R Prossnitz; Claire F Verschraegen
Estrogen and progesterone receptor status and outcome in epithelial ovarian cancers and low malignant potential tumors.
Gynecologic oncology 2009;114(3):480-5.
2009: Harriet O Smith; Hugo Arias-Pulido; Dennis Kuo; Tamara Howard; Clifford R Qualls; Sang-Joon Lee; Claire F Verschraegen; Helen J Hathaway; Nancy E Joste; Eric R Prossnitz
GPR30 predicts poor survival for ovarian cancer.
Gynecologic oncology 2009;114(3):465-71.
2009: Harriet O Smith; James Moon; Sharon P Wilczynski; Amy D Tiersten; Edward V Hannigan; William R Robinson; Saul E Rivkin; Garnet L Anderson; Ping-Yu Liu; Maurie Markman
Southwest Oncology Group Trial S9912: intraperitoneal cisplatin and paclitaxel plus intravenous paclitaxel and pegylated liposomal doxorubicin as primary chemotherapy of small-volume residual stage III ovarian cancer.
Gynecologic oncology 2009;114(2):206-9.
2009: Judith R Mourant; Tamara M Powers; Thérese J Bocklage; Heather M Greene; Maxine H Dorin; Alan G Waxman; Meggan M Zsemlye; Harriet O Smith
In vivo light scattering for the detection of cancerous and precancerous lesions of the cervix.
Applied optics 2009;48(10):D26-35.
2009: H Sayar; Z Shen; S J Lee; M Royce; I Rabinowitz; F Lee; Harriet O Smith; S Eberhardt; A Maestas; H Lu; C Verschraegen
Phase I study of capecitabine in combination with cisplatin and irinotecan in patients with advanced solid malignancies.
Investigational new drugs 2009;27(2):153-8.
2009: Amy D Tiersten; P Y Liu; Harriet O Smith; Sharon P Wilczynski; William R Robinson; Maurie Markman; David S Alberts
Phase II evaluation of neoadjuvant chemotherapy and debulking followed by intraperitoneal chemotherapy in women with stage III and IV epithelial ovarian, fallopian tube or primary peritoneal cancer: Southwest Oncology Group Study S0009.
Gynecologic oncology 2009;112(3):444-9.
2009: Amy D Tiersten; James Moon; Harriet O Smith; Sharon P Wilczynski; William R Robinson; Maurie Markman; David S Alberts
Chemotherapy resistance as a predictor of progression-free survival in ovarian cancer patients treated with neoadjuvant chemotherapy and surgical cytoreduction followed by intraperitoneal chemotherapy: a Southwest Oncology Group Study.
Oncology 2009;77(6):395-9.
2008: H Arias-Pulido; N Joste; A Chavez; C Y Muller; Donghai Dai; Harriet O Smith; C F Verschraegen
Absence of epidermal growth factor receptor mutations in cervical cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2008;18(4):749-54.
2008: Eric R Prossnitz; Jeffrey B Arterburn; Harriet O Smith; Tudor I Oprea; Larry A Sklar; Helen J Hathaway
Estrogen signaling through the transmembrane G protein-coupled receptor GPR30.
Annual review of physiology 2008;70():165-90.
2007: Judith R Mourant; Thérese J Bocklage; Tamara M Powers; Heather M Greene; Kathy L Bullock; Lisa R Marr-Lyon; Maxine H Dorin; Alan G Waxman; Meggan M Zsemlye; Harriet O Smith
In vivo light scattering measurements for detection of precancerous conditions of the cervix.
Gynecologic oncology 2007;105(2):439-45.
2007: Harriet O Smith; Kimberly K Leslie; Meenakshi Singh; Clifford R Qualls; Chetana M Revankar; Nancy E Joste; Eric R Prossnitz
GPR30: a novel indicator of poor survival for endometrial carcinoma.
American journal of obstetrics and gynecology 2007;196(4):386.e1-9; discussion 386.e9-11.
2006: Harriet O Smith; Charles Wiggins; Claire F Verschraegen; Laurence W Cole; Heather M Greene; Carolyn Y Muller; Clifford R Qualls
Changing trends in gestational trophoblastic disease.
The Journal of reproductive medicine 2006;51(10):777-84.
2006: Harriet O Smith; Marianne Berwick; Claire F Verschraegen; Charles Wiggins; Letitia Lansing; Carolyn Y Muller; Clifford R Qualls
Incidence and survival rates for female malignant germ cell tumors.
Obstetrics and gynecology 2006;107(5):1075-85.
2006: Gary L Goldberg; Paniti Sukumvanich; Mark Einstein; Harriet O Smith; Patrick S Anderson; Abbie L Fields
Total pelvic exenteration: the Albert Einstein College of Medicine/Montefiore Medical Center Experience (1987 to 2003).
Gynecologic oncology 2006;101(2):261-8.
2006: Harriet O Smith; Caroline S Jiang; Geoffrey R Weiss; Alton V Hallum; Ping-Yu Liu; W R Robinson; P C Cheng; Sidney A Scudder; Maurie Markman; David S Alberts
Tirapazamine plus cisplatin in advanced or recurrent carcinoma of the uterine cervix: a Southwest Oncology Group study.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16(1):298-305.
2005: Harriet O Smith; Ernest I Kohorn; Laurence A Cole
Choriocarcinoma and gestational trophoblastic disease.
Obstetrics and gynecology clinics of North America 2005;32(4):661-84.
2005: Laurence A Cole; Ernest I Kohorn; Harriet O Smith
Gestation trophoblastic diseases: management of cases with persistent low human chorionic gonadotropin results.
Obstetrics and gynecology clinics of North America 2005;32(4):615-26.
2005: Carolyn Y Muller; Harriet O Smith
Cervical neoplasia complicating pregnancy.
Obstetrics and gynecology clinics of North America 2005;32(4):533-46.
2005: Kanwaldeep Kaur Rasila; R A Burger; Harriet O Smith; Fa-Chyi Lee; Claire F Verschraegen
Angiogenesis in gynecological oncology-mechanism of tumor progression and therapeutic targets.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2005;15(5):710-26.
2005: Sidney A Scudder; Ping-Yu Liu; Sharon P Wilczynski; Harriet O Smith; Caroline Jiang; Alton V Hallum; Gregory B Smith; Edward V Hannigan; Maurie Markman; David S Alberts
Paclitaxel and carboplatin with amifostine in advanced, recurrent, or refractory endometrial adenocarcinoma: a phase II study of the Southwest Oncology Group.
Gynecologic oncology 2005;96(3):610-5.
2004: Mace L Rothenberg; Ping-Yu Liu; Sharon P Wilczynski; William A Nahhas; Gaye L Winakur; Caroline S Jiang; Carol M Moinpour; Ben Lyons; Geoffrey R Weiss; James H Essell; Harriet O Smith; Maurie Markman; David S Alberts
Phase II trial of vinorelbine for relapsed ovarian cancer: a Southwest Oncology Group study.
Gynecologic oncology 2004;95(3):506-12.
2004: Claire F Verschraegen; Harriet O Smith; Fa-Chyi Lee; Cynthia Cathcart; Jeffrey P Norenberg
TLK-286.
IDrugs : the investigational drugs journal 2004;7(8):771-81.
2004: Harriet O Smith; Clifford R Qualls; Robert D Hilgers; Claire F Verschraegen; William F Rayburn; Laurence W Cole; Luis A Padilla; Charles R Key
Gestational trophoblastic neoplasia in American Indians.
The Journal of reproductive medicine 2004;49(7):535-44.
2003: Harriet O Smith; Clifford R Qualls; Beth A Prairie; Luis A Padilla; William F Rayburn; Charles R Key
Trends in gestational choriocarcinoma: a 27-year perspective.
Obstetrics and gynecology 2003;102(5 Pt 1):978-87.
2003: Harriet O Smith
Gestational trophoblastic disease epidemiology and trends.
Clinical obstetrics and gynecology 2003;46(3):541-56.
2003: Sarah A Khanlian; Harriet O Smith; Laurence A Cole
Persistent low levels of human chorionic gonadotropin: A premalignant gestational trophoblastic disease.
American journal of obstetrics and gynecology 2003;188(5):1254-9.
2003: Maurie Markman; Tracy Glass; Harriet O Smith; Kenneth D Hatch; Geoffrey R Weiss; Sarah A Taylor; J Wendall Goodwin; David S Alberts
Phase II trial of single agent carboplatin followed by dose-intense paclitaxel, followed by maintenance paclitaxel therapy in stage IV ovarian, fallopian tube, and peritoneal cancers: a Southwest Oncology Group trial.
Gynecologic oncology 2003;88(3):282-8.
2003: Harriet O Smith; Robert D Hilgers; Edward J Bedrick; Clifford R Qualls; Charles Wiggins; William F Rayburn; Alan G Waxman; Nicole D Stephens; Laurence W Cole; Marian Swanson; Charles R Key
Ethnic differences at risk for gestational trophoblastic disease in New Mexico: A 25-year population-based study.
American journal of obstetrics and gynecology 2003;188(2):357-66.
2003: Edgar G Fischer; Therese Bocklage; Ian Rabinowitz; Harriet O Smith; David S Viswanatha
Primary plasmacytoma arising in an endocervical polyp with detection of neoplastic cells on papanicolaou test. A case report and review of the literature.
Archives of pathology & laboratory medicine 2003;127(1):e28-31.
2002: Harriet O Smith; Luis A Padilla
Adenocarcinoma in situ of the cervix: sensitivity of detection by cervical smear: will cytologic screening for adenocarcinoma in situ reduce incidence rates for adenocarcinoma.
Cancer 2002;96(6):319-22.
2002: Harriet O Smith; Clifford R Qualls; Audrey A Romero; Joel C Webb; Maxine H Dorin; Luis A Padilla; Charles R Key
Is there a difference in survival for IA1 and IA2 adenocarcinoma of the uterine cervix?
Gynecologic oncology 2002;85(2):229-41.
2002: Harriet O Smith; John A Blessing; Luis Vaccarello
Trimetrexate in the treatment of recurrent or advanced leiomyosarcoma of the uterus: a phase II study of the Gynecologic Oncology Group.
Gynecologic oncology 2002;84(1):140-4.
2001: Joel C Webb; Charles R Key; Clifford R Qualls; Harriet O Smith
Population-based study of microinvasive adenocarcinoma of the uterine cervix.
Obstetrics and gynecology 2001;97(5 Pt 1):701-6.
2000: Don M Morris; Harriet O Smith; Wei Liu; MC Genesen; D H Vander Jagt; Robert H Glew; Donald E Fry
Are antioxidant levels measured immediately postoperatively an indicator of magnitude of injury?
American journal of surgery 2000;180(3):212-6.
2000: Harriet O Smith; M F Tiffany; Clifford R Qualls; Charles R Key
The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States--a 24-year population-based study.
Gynecologic oncology 2000;78(2):97-105.
1999: Patrick S Anderson; Harriet O Smith; Gary L Goldberg; Abbie L Fields; Carolyn D Runowicz; Jeffrey W Pollard
Colony-stimulating factor-1 and its receptor do not have a role in the pathogenesis of uterine sarcomas.
Gynecologic oncology 1999;74(2):202-7.
1998: Harriet O Smith; MC Genesen; C D Runowicz; Gary L Goldberg
The rectus abdominis myocutaneous flap: modifications, complications, and sexual function.
Cancer 1998;83(3):510-20.
1996: Harriet O Smith; Dorothy N Kammerer-Doak; D M Barbo; G E Sarto
Hormone replacement therapy in the menopause: a pro opinion.
CA: a cancer journal for clinicians 1996;46(6):343-63.
1996: Dorothy N Kammerer-Doak; K Baurick; W Black; D M Barbo; Harriet O Smith
Endodermal sinus tumor and embryonal carcinoma of the ovary in a 53-year-old woman.
Gynecologic oncology 1996;63(1):133-7.
1996: M Schiff; Thomas M Becker; Harriet O Smith; Frank D Gilliland; Charles R Key
Ovarian cancer incidence and mortality in American Indian, Hispanic, and non-Hispanic white women in New Mexico.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1996;5(5):323-7.
1996: D H Tobias; Harriet O Smith; Carolyn D Runowicz; Gary L Goldberg
Laparoscopic surgery in patients with a ventriculoperitoneal shunt. A case report.
The Journal of reproductive medicine 1996;41(2):129-31.
1995: Harriet O Smith; C L DeVictoria; D Garfinkel; P Anderson; Gary L Goldberg; R Soeiro; G Elia; Carolyn D Runowicz
A prospective randomized comparison of an attached silver-impregnated cuff to prevent central venous catheter-associated infection.
Gynecologic oncology 1995;58(1):92-100.
1995: Harriet O Smith; P S Anderson; Dennis Kuo; Gary L Goldberg; C L DeVictoria; C A Boocock; J G Jones; Carolyn D Runowicz; E Richard Stanley; Jeffrey W Pollard
The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(3):313-25.
1995: D H Tobias; Harriet O Smith; J G Jones; P Anderson; Carolyn D Runowicz; Gary L Goldberg
Cutaneous metastases from squamous cell carcinoma of the vulva. A case report and review of the literature.
European journal of gynaecological oncology 1995;16(5):382-6.
1994: Gary L Goldberg; D G Gibbon; Harriet O Smith; C DeVictoria; Carolyn D Runowicz; Edward R Burns
Clinical impact of chemotherapy-induced thrombocytopenia in patients with gynecologic cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(11):2317-20.
1994: Dennis Kuo; Harriet O Smith; Carolyn D Runowicz; Gary L Goldberg
Cecal cancer in a teenager presenting with a pelvic mass: a case report and review of the literature.
Gynecologic oncology 1994;55(1):149-51.
1994: Therese Bocklage; Harriet O Smith; S A Bartow
Distinctive flow histogram pattern in molar pregnancies with elevated maternal serum human chorionic gonadotropin levels.
Cancer 1994;73(11):2782-90.
1994: Harriet O Smith; D E Gaudette; Gary L Goldberg; David Milstein; C L DeVictoria; Carolyn D Runowicz
Single-use percutaneous catheters for intraperitoneal P32 therapy.
Cancer 1994;73(10):2633-7.
1994: E A Poplin; D S Alberts; J J Rinehart; Harriet O Smith; J A Neidhart; Evan M Hersh
GM-CSF, carboplatin, doxorubicin: a phase I study.
Cancer chemotherapy and pharmacology 1994;33(4):340-6.
1994: Harriet O Smith; Gary L Goldberg; L Carol; S A Davidson; C Tomaino; L Centrilla; Carolyn D Runowicz
Dose escalation combination carboplatin/cyclophosphamide chemotherapy for epithelial ovarian cancer.
European journal of gynaecological oncology 1994;15(6):411-7.
1993: Scott Wadler; Hilda Haynes; Jonathan J Beitler; Gary L Goldberg; J F Holland; Howard Hochster; H Bruckner; John Mandeli; Harriet O Smith; Carolyn D Runowicz
Management of hypocalcemic effects of WR2721 administered on a daily times five schedule with cisplatin and radiation therapy. The New York Gynecologic Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(8):1517-22.
1993: Carolyn D Runowicz; Gary L Goldberg; Harriet O Smith
Cancer screening for women older than 40 years of age.
Obstetrics and gynecology clinics of North America 1993;20(2):391-408.
1993: C D Runowicz; Harriet O Smith; Gary L Goldberg
Multimodality therapy in locally advanced cervical cancer.
Current opinion in obstetrics & gynecology 1993;5(1):92-8.
1993: Harriet O Smith; C Allen Stringer; John J Kavanagh; David M Gershenson; Creighton L Edwards; J Taylor Wharton
Treatment of advanced or recurrent squamous cell carcinoma of the uterine cervix with mitomycin-C, bleomycin, and cisplatin chemotherapy.
Gynecologic oncology 1993;48(1):11-5.
1992: Holly H Gallion; P Y Liu; D E Alberts; R V O'Toole; J O'Sullivan; G Mills; Harriet O Smith; H E Hynes
Phase II trial of amonafide in previously treated patients with advanced ovarian cancer: a Southwest Oncology Group study.
Gynecologic oncology 1992;46(2):230-2.
1992: E Poplin; Harriet O Smith; B Behrens; Bruce G Redman; Lawrence E Flaherty; J Neidhart; D Alberts
SWOG 8825: melphalan GM-CSF: a phase I study.
Gynecologic oncology 1992;44(1):66-70.
1991: Harriet O Smith; R V Worrell; A Y Smith; Maxine H Dorin; R D Rosenberg; S A Bartow
Aggressive angiomyxoma of the female pelvis and perineum: review of the literature.
Gynecologic oncology 1991;42(1):79-85.
1987: Harriet O Smith; A A Toledo; J D Thompson
Conservative surgical management of isthmic ectopic pregnancies.
American journal of obstetrics and gynecology 1987;157(3):604-10.